JYNT vs VRTX · P/E 92, rev $30.0M vs P/E 30, rev $3.33B
The Joint Corp (JYNT) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
The Joint Corp (JYNT) is a medical care facilities company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported JYNT revenue for 2026-06-30 was $30.0M. Net income was $2.0M. JYNT currently screens at market cap $117.9M and trailing P/E 91.9.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
JYNT currently screens at market cap $117.9M and trailing P/E 91.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the JYNT and VRTX stock pages for the full models.
Not investment advice.